Evidence map›Paper›PMID 36984881›Full record

ArticleMetabolites2023

A Pilot Study on Biochemical Profile of Follicular Fluid in Breast Cancer Patients.

Maria A Castiglione Morelli, Assunta Iuliano, Ilenia Matera, Licia Viggiani, Sergio C A Schettini, Paola Colucci, Angela Ostuni

Abstract read
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria A Castiglione MorelliDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.ORCID 0000-0003-3967-3117
Assunta IulianoCenter for Reproductive Medicine of "San Carlo" Hospital, 85100 Potenza, Italy.ORCID 0000-0002-4531-4383
Ilenia MateraDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.
Licia ViggianiDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.
Sergio C A SchettiniCenter for Reproductive Medicine of "San Carlo" Hospital, 85100 Potenza, Italy.
Paola ColucciCenter for Reproductive Medicine of "San Carlo" Hospital, 85100 Potenza, Italy.
Angela OstuniDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.ORCID 0000-0001-5970-5097

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is the most common type of cancer among women in almost all countries worldwide and is one of the oncological pathologies for which is indicated fertility preservation, a type of procedure used to help keep a person's ability to have children. Follicular fluid (FF) is a major component of oocyte microenvironment, which is involved in oocyte growth, follicular maturation, and in communication between germ and somatic cells; furthermore, it accumulates all metabolites during oocytes growth. To obtain information about changes on fertility due to cancer, we aimed at investigating potential biomarkers to discriminate between FF samples obtained from 16 BC patients and 10 healthy women undergoing in vitro fertilization treatments. An NMR-based metabolomics approach was performed to investigate the FF metabolic profiles; ELISA and western blotting assays were used to investigate protein markers of oxidative and inflammatory stress, which are processes closely related to cancer. Our results seem to suggest that FFs of BC women display some significant metabolic alterations in comparison to healthy controls, and these variations are also related with tumor staging.

Indexed as

breast cancerfertility preservationinflammationNMR-based metabolomicsoxidative stresstumor stage

Identifiers

PMID36984881
PMCPMC10054828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.